Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma

European Urology

Volume 82, Issue 4, October 2022, Pages 363-364

M. Kulis et al.
DNA methylation and cancer
Adv Genet
(2010)
S. Zaman et al.
Aberrant epidermal growth factor receptor RNA splice products are among the most frequent somatic alterations in clear cell renal cell carcinoma and are associated with a poor response to immunotherapy
Eur Urol Focus
(2021)
F.E. Baralle et al.
Alternative splicing as a regulator of development and tissue identity
Nat Rev Mol Cell Biol
(2017)
C. Di et al.
Function, clinical application, and strategies of Pre-mRNA splicing in cancer
Cell Death Differ
(2019)
S.C. Bonnal et al.
Roles and mechanisms of alternative splicing in cancer - implications for care
Nat Rev Clin Oncol
(2020)
J. Zhang et al.
Misregulation of pre-mRNA alternative splicing in cancer
Cancer Discov
(2013)

There are more references available in the full text version of this article.